These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Klein W; Tromm A; Griga T; Fricke H; Folwaczny C; Hocke M; Eitner K; Marx M; Runte M; Epplen JT Electrophoresis; 2000 Nov; 21(17):3578-82. PubMed ID: 11271474 [TBL] [Abstract][Full Text] [Related]
25. Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease. Aizawa Y; Sutoh S; Matsuoka M; Negishi M; Torii A; Miyakawa Y; Sugisaka H; Nakamura M; Toda G Tissue Antigens; 2005 Jan; 65(1):88-92. PubMed ID: 15663745 [TBL] [Abstract][Full Text] [Related]
26. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129 [TBL] [Abstract][Full Text] [Related]
27. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases. Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906 [TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Karlsen TH; Hampe J; Wiencke K; Schrumpf E; Thorsby E; Lie BA; Broomé U; Schreiber S; Boberg KM Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974 [TBL] [Abstract][Full Text] [Related]
29. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Baumgart DC; Buning C; Geerdts L; Schmidt HH; Genschel J; Fiedler T; Gentz E; Molnar T; Nagy F; Lonovics J; Lochs H; Wiedenmann B; Nickel R; Witt H; Dignass A Digestion; 2007; 76(3-4):196-202. PubMed ID: 18174680 [TBL] [Abstract][Full Text] [Related]
30. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review. Abdollahi E; Tavasolian F; Momtazi-Borojeni AA; Samadi M; Rafatpanah H J Immunotoxicol; 2016 May; 13(3):286-300. PubMed ID: 27043356 [TBL] [Abstract][Full Text] [Related]
31. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Cao Q; Zhu Q; Shang Y; Gao M; Si J Digestion; 2009; 79(1):58-63. PubMed ID: 19252404 [TBL] [Abstract][Full Text] [Related]
32. The role of fatty acid hydrolase gene variants in inflammatory bowel disease. Storr M; Emmerdinger D; Diegelmann J; Yüce B; Pfennig S; Ochsenkühn T; Göke B; Lohse P; Brand S Aliment Pharmacol Ther; 2009 Mar; 29(5):542-51. PubMed ID: 19053981 [TBL] [Abstract][Full Text] [Related]
33. Evidence for association of OCTN genes and IBD5 with ulcerative colitis. Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305 [TBL] [Abstract][Full Text] [Related]
34. TNFalpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Castro-Santos P; Suarez A; López-Rivas L; Mozo L; Gutierrez C Am J Gastroenterol; 2006 May; 101(5):1039-47. PubMed ID: 16573780 [TBL] [Abstract][Full Text] [Related]
35. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis. Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120 [TBL] [Abstract][Full Text] [Related]
36. Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population. Newman WG; Zhang Q; Liu X; Amos CI; Siminovitch KA J Clin Gastroenterol; 2009; 43(5):444-7. PubMed ID: 19276991 [TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of interleukin-23 receptor in patients with inflammatory bowel disease in a Croatian tertiary center. Mihaljević S; Kibel A; Stefanić M; Glavas-Obrovac L; Takac B; Krznarić Z; Samardiija M; Pinotić L; Milas J; Segec I Coll Antropol; 2013 Dec; 37(4):1171-7. PubMed ID: 24611330 [TBL] [Abstract][Full Text] [Related]
38. Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4 Nie J; Zhao Q Front Immunol; 2020; 11():852. PubMed ID: 32547537 [No Abstract] [Full Text] [Related]
39. Pilot study of variants of the IL-23R and STAT3 genes reveals no association with Hashimoto's thyroiditis in the Croatian population. Stevic MS; Stefanic M; Tokic S; Glavas-Obrovac L; Mihaljevic S; Karner I Endocr Res; 2014; 39(4):164-7. PubMed ID: 24460100 [TBL] [Abstract][Full Text] [Related]
40. Lack of Association between Interleukin 23R (IL-23R) rs10889677 Polymorphism and Inflammatory Bowel Disease Susceptibility In an Iranian Population. Karimkhani S; Chaleshi V; Balaii H; Tarban P; Nourian M; Irani S; Shahrokh S; Asadzadeh Aghdaei H; Mohammad Alizadeh AH; Norouzinia M; Zali MR Rep Biochem Mol Biol; 2018 Oct; 7(1):16-22. PubMed ID: 30324113 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]